Clarity's intended service model includes core launch services, medical and pharmacological services provided through affiliated medical practices, and specialized programs introduced according to staffing and operational readiness.
Patients may begin with a comprehensive assessment, bring an existing diagnosis, or access targeted support that fits their clinical needs.
Support for the whole picture.
SERVICES
HOW WE HELP
Core Services
Assessment and Care
Planning
-
Comprehensive psychological and psychoeducational assessment
-
Diagnostic and functional formulation
-
Individualized Clarity Care Maps
Therapy and Executive
Function
-
ADHD-adapted cognitive behavioural therapy
-
Executive-function intervention and coaching
-
Emotional-regulation treatment
Family, School, and
Lifestyle Support
-
Parent behaviour-management programs
-
School, university, and workplace support
-
Sleep and lifestyle intervention
Progress and Behaviour Monitoring
-
Measurement-based outcome monitoring
-
Digital behaviour management
INNOVATIVE CARE, CAREFULLY INTEGRATED
Advanced care for complex needs
Precision
Pharmacology
This service integrates medication history, treatment response, adverse effects, pharmacokinetics, drug interactions, and selected pharmacogenomic findings.
Potential areas may include:
-
CYP2D6 and atomoxetine
-
CES1 and methylphenidate metabolism
-
COMT-related exploratory information
-
Cautious interpretation of MTHFR findings
-
Pharmacogenomic guidance for medications used for co-occurring anxiety or depression
Pharmacogenomic findings are considered alongside the patient’s overall clinical profile and do not guarantee a diagnosis or ideal medication.
Clarity
Neuroregulation
Clarity Neuroregulation is an individualized adjunctive service that may include:
-
19-channel quantitative EEG assessment
-
Individualized neurofeedback protocols
-
Attention and working-memory performance measures
-
Personalized regulation targets
-
Repeated within-person outcome measurement
-
Integration with psychological, executive-function, and medication treatment
Neuroregulation is presented as an adjunctive intervention with evolving evidence, not as a cure or guaranteed alternative to medication.
Trauma and
Emotional Health
This area recognizes how trauma and adversity may affect attention, emotional regulation, mood, behaviour, substance-use vulnerability, and long-term mental health.
​Appropriately trained clinicians may provide:
-
Trauma-informed assessment
-
Trauma-focused cognitive behavioural therapy
-
EMDR where clinically indicated
-
Emotional-regulation treatment
-
Treatment of co-occurring anxiety and depression
EMDR is used to address trauma-related concerns rather than as a primary treatment for the core symptoms of ADHD.
Medical and Pharmacological Services
Medication and clinical pharmacology services may be provided through affiliated medical practices and led by Dr. Baweja and Dr. Khattak.
​
Insured physician services and privately funded Clarity services are provided separately. Patients are not required to purchase private services to access insured medical care.
Services may include:
-
Medication selection, adjustment, and monitoring
-
Management of side effects or partial treatment response
-
Complex medication consultations
-
Review of drug interactions and multiple medications
-
ADHD treatment alongside anxiety, depression, autism, tic disorders, and other co-occurring conditions
-
Support during the transition from paediatric to adult care
-
Clinical pharmacology consultation
-
And selective interpretation of pharmacogenomic testing.